Arcus Biosciences, Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
RCUS on NYSE
Industry
Pharmaceutical Preparations
Location
3928 Point Eden Way, Hayward, CA

Insiders trading volume in the past year

Arcus Biosciences, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Gilead Sciences, Inc. 10%+ Owner $346M +$15M +4.54% Feb 18, 2025
Terry J. Rosen Chief Executive Officer, Director $26M +$201K +0.78% Feb 27, 2025
Juan C. Jaen President $23.3M Jan 23, 2025
Yasunori Kaneko Director $9.45M +$201K +2.18% Feb 27, 2025
Jennifer Jarrett Chief Operating Officer $3.2M Jan 23, 2025
Kathryn E. Falberg Director $2.76M Jun 6, 2024
Carolyn Tang General Counsel $2.06M Jan 23, 2025
Robert Goeltz II Chief Financial Officer $1.46M -$53.9K -3.57% Jan 23, 2025
Dimitry SA Nuyten Chief Medical Officer $1.41M Dec 15, 2024
Richard Markus Chief Medical Officer $1.13M Feb 10, 2025
David L. Lacey Director $865K Jan 23, 2025
Antoni Ribas Director $584K Jan 23, 2025
Andrew J. Perlman Director $515K Jun 6, 2024
Alexander Azoy Chief Accounting Officer $453K -$23.4K -4.91% Jan 23, 2025
Patrick Machado Director $444K Jun 6, 2024
Nicole Lambert Director $421K Jun 6, 2024
William Grossman Chief Medical Officer $414K Jun 16, 2021
Dietmar Berger Director $0 Feb 6, 2025
Johanna Mercier Director $0 Jan 29, 2024
Linda Slanec Higgins Director Aug 10, 2021

Recent Insider Transactions by Companies or Individuals for Arcus Biosciences, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.